Xiaoya Sun

Xiaoya Sun

Auto-generated profile, based on publicly available information

Xiaoya Sun

Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
XSXiaoya Sun
Xiaoya Sun
ZCZiqiang Cao
Ziqiang Cao
YMYuanyuan Ma
Yuanyuan Ma
YSYimin Shao
Yimin Shao
JZJunqing Zhang
Junqing Zhang
XGXiaohui Guo
Xiaohui Guo
Dapagliflozin alleviates hyperglycemia by increasing glycosuria, but it induces renal gluconeogenesis, thus neutralizing its efficacy. Resveratrol (Rsv), a natural polyphenolic chemical, improves insulin sensitivity in type 2 diabetes (T2D). Here, we investigated the regulatory effects and underlying mechanisms of Rsv on dapagliflozin-induced renal gluconeogenesis. Male ob/ob mice were given the vehicle (HF), dapagliflozin (1 mg kg−1), Rsv (10 mg kg−1), or dapagliflozin and Rsv combination for 10 weeks. Glucose metabolism was evaluated by glucose and pyruvate tolerance tests. HK-2 cells (human renal proximal tubule cells) were treated with dapagliflozin (1 μmol L−1) for 2 h and further incubated with Rsv (10 μmol L−1) for 12 h. The effects of Rsv on gluconeogenesis and insulin signaling were assessed. Dapagliflozin treatment increased glucose production in HK-2 cells and lowered blood glucose and induced gluconeogenesis in ob/ob mice. After Rsv treatment, the enhanced glucose production and gluconeogenesis were alleviated. The upregulated mRNA and protein expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) and the activation of the forkhead transcription factor O1 (FoxO1) protein in the dapagliflozin group were attenuated by Rsv administration. Rsv also improved renal insulin signaling by increasing PI3K and Akt phosphorylation. The PI3K inhibitor LY294002 dramatically decreased the p-Akt expression and activated FoxO1 by dephosphorylation, thus diminishing the inhibitory effects of Rsv on dapagliflozin-induced PEPCK and G6Pase expression. The data showed the mechanisms of Rsv in attenuating dapagliflozin-induced renal gluconeogenesis via activating the PI3K/Akt pathway and further suppressing FoxO1 activation, suggesting a potential intervention to achieve better glucose-lowering effects for SGLT2 inhibitors in T2D therapy.


24 March 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
XSXiaoya Sun
Xiaoya Sun
Aims: Angiopoietin-like protein 8 (ANGPTL8), a secreted adipokine, has been reported to be associated with lipid and glucose metabolism. This study aimed to evaluate the association between circulating levels of ANGPTL8 and atherogenic risk, assessed by the atherogenic index of plasma (AIP), in diabetic individuals. Methods: A total of 228 patients with type 2 diabetes (T2D) were included in this cross-sectional study. The AIP was calculated as the logarithm of the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-c) and divided into two subgroups of low and high risk of CVD, as <0.11 and ≥0.11, respectively. Data including clinical characteristics and laboratory tests were collected. Serum levels of ANGPTL8 were assessed by ELISA analysis. Results: Serum concentrations of ANGPTL8 were significantly higher in the high AIP group compared with the low AIP group [293.84 (255.63–332.05) ng/mL vs. 223.05 (202.85–243.25) ng/mL; P < 0.001]. Serum ANGPTL8 levels were positively correlated with AIP values in patients with T2D as shown by Spearman correlation analysis (r = 0.133, P < 0.05). After adjusting for confounding factors, elevated ANGPTL8 levels remained significantly associated with high AIP (OR, 0.010; 95% CI: 0.994–0.999; P < 0.010). The optimal cutoff value of ANGPTL8 for identifying high AIP was 227.18 ng/mL (sensitivity = 68.40%; specificity = 68.00%; P < 0.001; AUC = 0.780; 95% CI: 0.714–0.847). Conclusions: : The serum ANGPTL8 levels are elevated in T2D patients with high AIP. Increased ANGPTL8 levels are closely associated with higher AIP values, indicating a predictive value of ANGPTL8 in atherosclerosis in patients with T2D.